Page last updated: 2024-10-31

neostigmine and Chromosomal Translocation

neostigmine has been researched along with Chromosomal Translocation in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"This congenital myasthenic syndrome is for the first time associated with an autosomal translocation 2q31-9p27."1.31[Slow channel syndrome due to an autosomal translocation at 2q31-9p27]. ( Crielaard, JM; Hansen, I; Wang, FC; Zeevaert, B, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zeevaert, B1
Hansen, I1
Crielaard, JM1
Wang, FC1

Other Studies

1 other study available for neostigmine and Chromosomal Translocation

ArticleYear
[Slow channel syndrome due to an autosomal translocation at 2q31-9p27].
    Revue neurologique, 2002, Volume: 158, Issue:5 Pt 1

    Topics: Action Potentials; Adult; Autoimmune Diseases; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair

2002